Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Shire Builds Confidence In $20bn Revenue Target

Nov 15 2016

• By Sukaina Virji

Related Content

Baxalta Brings Japan Suit Against Chugai Hemophilia Antibody

May 13 2016

Shire Plays Up Xiidra Launch, Downplays Missed Sales Expectations

Nov 01 2016

Shire Exits Biosimilars, Streamlines Oncology Business

Nov 02 2016

Related Companies

Takeda Pharmaceutical Co. Ltd.

Novo Nordisk A/S

Additional Topics

Commercial Rare Diseases Blood & Coagulation Disorders BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window